Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Apr 2020 for Ra Pharmaceuticals, Inc., €479k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
John C. King: trading record in brief
All filings by John C. King on record concern Ra Pharmaceuticals, Inc. Between 16 April 2019 and 2 April 2020, the trades on record add up to 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 April 2020, the filings show a transaction worth €479k in Ra Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John C. King
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
10,823 shares@ US$48.00100.0% of flowCommon StockSEC:0001104659-20-042766:0
15,329 sharesCommon StockSEC:0001104659-19-022403:0
4,506 shares@ US$21.9315.5% of flowCommon StockSEC:0001104659-19-022403:1
3 of 3 declarations
